ChromoCure, Inc. Launches Nationwide Diagnostic Lab Partnership Program
1:52 pm ET 11/03/2009 - Market Wire
RENO, NV -- (MARKET WIRE) -- 11/03/09 --
Chromocure. Inc. (PINKSHEETS: KKUR) announced its
partnership program for cancer diagnostic laboratories and research
centers.
Industry pathologists and cancer diagnostic research centers may request
the company's partnership package and materials at:
http://chromocure.com/services/pathology-request/
Pathology labs will receive ChromoCure's CS200 Chromosomal Scanner
installed on their premises without cost. ChromoCure will provide
training, material, and marketing guidance. Established insurance codes
exist for ease of billing and collections. The ChromoCure CS200 can
deliver immediate revenue to pathologists.
Cancer research centers may purchase the company's equipment or use one of the company's network pathology labs to perform chromosomal scans.
Preferred pricing will be extended to all cancer research partners.
Purchasers of the CS200 chromosomal scanner will receive a favorable
upgrade price to the CS300 series when released.
The company has established this special program to expand it network of
pathology labs as well as promote its science and technology with cancer
research centers.